Evidence

See the contribution.
Examine the evidence.

Scientific cases, selected publications and funded research show the questions we investigate and the work behind our approach.

Scientific cases

Questions, methods and findings.

Design followed by experimental testing

Experimentally tested chemistry

DNMT1

Mechanistic insight into new inhibitor chemistry.

Read the case

Mechanistic design and experimental testing

NOTUM

A transient feature opened a design opportunity.

Read the case

Interpretation of existing evidence

Computational interpretation

SHP1 / SHP2

Understand selectivity beyond the local active site.

Read the case

Retrospective study of published ligands

JAK3

Examine covalent behaviour in context.

Read the case

Selected research & perspectives

Explore the scientific foundations.

Research into molecular mechanisms, quantum methods and their role in discovery.

Quantum chemistry informs our scientific workflows today. Research into quantum computing explores further computational possibilities; the publications below distinguish these areas.

Molecular visualisation from Kuano’s IRAP research
Molecular visualisation associated with Kuano’s IRAP research.

Original research · 2025

Molecular insight into IRAP activity and inhibition

Journal of Chemical Information and Modeling

Hanževački and colleagues, including Will Gerrard, David Wright, Vid Stojevic and Adrian Mulholland.

QM/MM simulations examine why oxytocin and angiotensin IV behave differently in IRAP. The study connects molecular mechanism with the interpretation of activity and inhibition.

Read the research

Review / perspective · 2025

What is the future role of quantum computation in drug discovery?

Emerging Topics in Life Sciences

Georg Schusteritsch, David Wright, Andrew Green and Vid Stojevic.

A practical discussion of quantum computing in discovery: promising scientific questions, the relationship to classical methods and the limitations that still need to be addressed.

Read the review

Industry commentary · October 2025

Redefining drug discovery using quantum physics

MedNous

Jarryl D’Oyley and Catherine Stace.

An accessible account of how physics can inform molecular design, and why understanding a reaction can open new discovery opportunities.

Read the article PDF

Foundational research · 2021

Parallel quantum simulation of large systems on small NISQ computers

npj Quantum Information

Fergus Barratt and colleagues, including Vid Stojevic and Andrew Green.

Tensor-network methods explore how limited quantum computing resources can represent larger systems. Selected work by our team and advisers, presented with the original research affiliations.

View the paper and publication record

Funded research

From scientific questions
to research programmes.

Publicly funded projects have supported Kuano’s work in molecular design and advanced computation.

Innovate UK · 2023–2025 · Closed

Quantum computing for enzyme-targeted discovery

A feasibility study with UCL and the NQCC exploring quantum simulation approaches for complex enzyme systems, including metalloenzymes.

View the UKRI project record

Innovate UK · 2022–2024 · Closed

NOTUM inhibitor discovery

A preclinical discovery project applying molecular simulation and design to NOTUM inhibitors for colorectal cancer. Mechanistic insight informed chemistry that was synthesised and tested.

View the UKRI project record
Earlier funded research
  • Quantum techniques and transition-state modelling · 2021–2023

    ISCF-supported feasibility research into quantum approaches for molecular simulation.

    UKRI project record
  • Combined AI and modelling for rapid-response drug design · 2020–2021

    An Innovate UK project investigating how AI and simulation could support drug-design decisions.

    UKRI project record

Platform workflow

Connect investigation with molecular design.

Explore how scientific questions, coordinated calculations and reviewed evidence inform generative molecular design under scientist direction and review.

View the illustrative workflow